Geographical Patterns and Risk Factor Association of Cardio-Oncology Mortality in the United States.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 08 2023
Historique:
received: 07 03 2023
revised: 16 05 2023
accepted: 06 06 2023
pmc-release: 15 08 2024
medline: 31 7 2023
pubmed: 30 6 2023
entrez: 29 6 2023
Statut: ppublish

Résumé

Cardio-oncology mortality (COM) is a complex issue that is compounded by multiple factors that transcend a depth of socioeconomic, demographic, and environmental exposures. Although metrics and indexes of vulnerability have been associated with COM, advanced methods are required to account for the intricate intertwining of associations. This cross-sectional study utilized a novel approach that combined machine learning and epidemiology to identify high-risk sociodemographic and environmental factors linked to COM in United States counties. The study consisted of 987,009 decedents from 2,717 counties, and the Classification and Regression Trees model identified 9 county socio-environmental clusters that were closely associated with COM, with a 64.1% relative increase across the spectrum. The most important variables that emerged from this study were teen birth, pre-1960 housing (lead paint indicator), area deprivation index, median household income, number of hospitals, and exposure to particulate matter air pollution. In conclusion, this study provides novel insights into the socio-environmental drivers of COM and highlights the importance of utilizing machine learning approaches to identify high-risk populations and inform targeted interventions for reducing disparities in COM.

Identifiants

pubmed: 37385168
pii: S0002-9149(23)00417-4
doi: 10.1016/j.amjcard.2023.06.037
pmc: PMC10529631
mid: NIHMS1910701
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

150-157

Subventions

Organisme : NIMHD NIH HHS
ID : P50 MD017351
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Dr. Dong is supported by contracts from the Cleveland Clinic Foundation, including a subcontract from Celgene Corporation. The remaining authors have no conflicts of interest to declare.

Références

JACC CardioOncol. 2021 Jun;3(2):201-204
pubmed: 34308372
Environ Res. 1985 Oct;38(1):46-53
pubmed: 4076111
Circulation. 2016 Mar 15;133(11):1104-14
pubmed: 26976915
Eur Heart J. 2000 Jul;21(14):1141-51
pubmed: 10924297
CA Cancer J Clin. 2019 Sep;69(5):363-385
pubmed: 31184787
Sci Rep. 2023 Feb 20;13(1):2978
pubmed: 36808141
J Am Coll Cardiol. 2018 Oct 23;72(17):2054-2070
pubmed: 30336830
Am J Epidemiol. 2017 Oct 15;186(8):961-969
pubmed: 28541385
Am J Public Health. 1992 Jun;82(6):816-20
pubmed: 1585961
JAMA Netw Open. 2022 Sep 1;5(9):e2230925
pubmed: 36083583
Lancet Oncol. 2014 Jan;15(1):35-47
pubmed: 24314616
Clin J Oncol Nurs. 2021 Oct 1;25(5):36-41
pubmed: 34533529
Am J Kidney Dis. 2023 Apr;81(4):497-499
pubmed: 36396086
Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):66-76
pubmed: 34697059
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
N Engl J Med. 2021 Nov 11;385(20):1881-1892
pubmed: 34758254
Public Health Rep. 2013 Mar-Apr;128 Suppl 1:5-22
pubmed: 23450881
Ann N Y Acad Sci. 2008;1136:276-88
pubmed: 18579887
Am J Public Health. 2003 Jul;93(7):1137-43
pubmed: 12835199
Eur Heart J. 2022 Nov 1;43(41):4229-4361
pubmed: 36017568
J Community Health. 2010 Feb;35(1):76-80
pubmed: 19949844
J Am Heart Assoc. 2021 Dec 21;10(24):e023852
pubmed: 34913366
Cardiooncology. 2021 Mar 20;7(1):11
pubmed: 33743837
Am J Public Health. 2002 May;92(5):769-72
pubmed: 11988444

Auteurs

Issam Motairek (I)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Weichuan Dong (W)

Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Pedro Rvo Salerno (PR)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Scott E Janus (SE)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Sarju Ganatra (S)

Cardio-Oncology Program, Lahey Clinic, Burlington, Massachusetts.

Zhuo Chen (Z)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Avirup Guha (A)

Cardio-Oncology Program, Georgia Cancer Center, Medical College of Georgia at Augusta University, Augusta, Georgia.

Mohamed He Makhlouf (MH)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Neda Shafiabadi Hassani (NS)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Sanjay Rajagopalan (S)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio; Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Sadeer G Al-Kindi (SG)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio; Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio. Electronic address: Sadeer.Al-Kindi@uhhospitals.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH